This is not the most recent version of the article. View current version (9 OCT 2013)

Intervention Review

Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients

  1. Liat Vidal1,*,
  2. Itsik Ben dor2,
  3. Mical Paul3,
  4. Ellisheva Pokroy4,
  5. Karla Soares-Weiser5,
  6. Leonard Leibovici1

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 18 OCT 2004

Assessed as up-to-date: 31 AUG 2007

DOI: 10.1002/14651858.CD003992.pub2


How to Cite

Vidal L, Ben dor I, Paul M, Pokroy E, Soares-Weiser K, Leibovici L. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD003992. DOI: 10.1002/14651858.CD003992.pub2.

Author Information

  1. 1

    Beilinson Campus, Rabin Medical Center, Department of Medicine E, Petah-Tiqva, Israel

  2. 2

    Rabin Medical Center, Department of Internal Medicine E, Petah-Tikva, Israel

  3. 3

    Rabin Medical Center, Infectious Diseases Unit and Department of Medicine E, Petah-Tikva, Israel

  4. 4

    Rabin Medical Center, Beilinson Campus, Department of Internal Medicine A, Petah-Tikva, Israel

  5. 5

    Enhance Reviews, Kfar-Saba, Israel

*Liat Vidal, Department of Medicine E, Beilinson Campus, Rabin Medical Center, 39 Jabotinsky Street, Petah-Tiqva, 49100, Israel. vidall@clalit.org.il. vidallit@yahoo.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2004

SEARCH

This is not the most recent version of the article. View current version (09 OCT 2013)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Meret Henry, Lillian Sung, Supportive Care in Pediatric Oncology, Pediatric Clinics of North America, 2015, 62, 1, 27

    CrossRef

  2. 2
    E. Bergot, Aplasie fébrile du cancer bronchique, Revue des Maladies Respiratoires Actualités, 2013, 5, 1, 37

    CrossRef

  3. 3
    Aditi Vedi, Richard Cohn, Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia, Journal of Paediatrics and Child Health, 2013, 49, 3
  4. You have free access to this content4
    S. Lingaratnam, M. A. Slavin, L. Mileshkin, B. Solomon, K. Burbury, J. F. Seymour, R. Sharma, B. Koczwara, S. W. Kirsa, I. D. Davis, M. Prince, J. Szer, C. Underhill, O. Morrissey, K. A. Thursky, An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009, Internal Medicine Journal, 2011, 41, 1b
  5. 5
    Marlon Saria, Preventing and Managing Infections in Neutropenic Stem Cell Transplantation Recipients: Evidence-Based Review, Clinical Journal of Oncology Nursing, 2011, 15, 2, 133

    CrossRef

  6. 6
    Despina G. Contopoulos-Ioannidis, Maria S. Baltogianni, John P.A. Ioannidis, Comparative Effectiveness of Medical Interventions in Adults Versus Children, The Journal of Pediatrics, 2010, 157, 2, 322

    CrossRef

  7. 7
    E. Bergot, Prise en charge des neutropénies fébriles au cours du cancer bronchique, Revue des Maladies Respiratoires Actualités, 2010, 2, 3, 252

    CrossRef

  8. 8
    H.M. Ziglam, K. Gelly, W. Olver, A survey of the management of neutropenic fever in oncology units in the UK, International Journal of Antimicrobial Agents, 2007, 29, 4, 430

    CrossRef

  9. 9
    Anastasia Antoniadou, Helen Giamarellou, Fever of Unknown Origin in Febrile Leukopenia, Infectious Disease Clinics of North America, 2007, 21, 4, 1055

    CrossRef

  10. 10
    Axel Glasmacher, Marie von Lilienfeld-Toal, An evidence based review of the available antibiotic treatment options for neutropaenic patients and a recommendation for treatment guidelines, International Journal of Infectious Diseases, 2006, 10, S9

    CrossRef

  11. 11
    Montserrat Batlle, Natalia Lloveras, Manejo del paciente con neutropenia de bajo riesgo y fiebre, Enfermedades Infecciosas y Microbiología Clínica, 2005, 23, 30

    CrossRef

  12. 12
    Rodolfo Rivas-Ruiz, Miguel Villasis-Keever, Maria G Miranda-Novales, Outpatient treatment for patients with cancer who develop a low-risk febrile neutropenic event, The Cochrane Library,